Oluwaseun D. Akanbi

Oluwaseun D. Akanbi

Auto-generated profile, based on publicly available information

Oluwaseun D. Akanbi

Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2025 in Science Advances
Verified
Journal Article
Open access
JLJonathan K. Lee
Jonathan K. Lee
MGM. Guevara
M. Guevara
OAOluwaseun D. Akanbi
Oluwaseun D. Akanbi
JHJ. Damon Hoff
J. Damon Hoff
DKDaniel Kupor
Daniel Kupor
OAOmolola Eniola Adefeso
Omolola Eniola Adefeso
Particle elasticity has widely been established to substantially influence immune cell clearance and circulation time of vascular-targeted carriers (VTCs). However, prior studies have primarily investigated interactions with macrophages, monocytic cell lines, and in vivo murine models. Interactions between particles and human neutrophils remain largely unexplored, although they represent a critical aspect of VTC performance. Here, we explore the impact of particle elasticity on primary human neutrophil phagocytosis using polyethylene glycol–based particles of different elastic moduli. We found that neutrophils effectively phagocytose deformable particles irrespective of their modulus, indicating a departure from established phagocytosis trends seen with other types of immune cells. These findings highlight the observed phenotypic difference between different types of phagocytes and underscore the need to characterize VTC performance using various cell types and animal models that represent human systems closely.

20 February 2026 in Science Advances
Verified
Journal Article
Open access
OAOluwaseun D. Akanbi
Oluwaseun D. Akanbi
MFMichael L. Felder
Michael L. Felder
DKDaniel Kupor
Daniel Kupor
JFJiachen Feng
Jiachen Feng
LCLuana Janaína de Campos
Luana Janaína de Campos
OAOmolola Eniola Adefeso
Omolola Eniola Adefeso
Steroids, specifically bile salts and corticosteroids, treat bile synthesis disorders, liver dysfunction, and inflammation. However, these water-soluble steroid drugs are rapidly cleared from the desired sites of action in the body, necessitating multiple doses. Therefore, the development of particle-based steroid medications that offer elongated therapeutic activity is of paramount medical importance. Accordingly, steroid microparticles were developed via three fabrication processes in this work, where a metal or an organic acid facilitates steroid microparticle formation. Particles fabricated using these methods exhibit consistent shape, size, and crystallinity. Furthermore, results from our coarse-grained computational model show that hydrogen bonding dictates steroid monomer-monomer interactions that determine overall particle shape and size. In addition, we demonstrate the ability to induce steroid particle formation and tune the morphology of steroid drug particles by replacing the C21 side group (tail) with chemical analogs. Thus, this study opens opportunities for the clinical translation of particle-based steroid therapeutics as an alternative to the current steroid drug formulations.